5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase

Journal of Applied Physiology

Volumn 99, Issue 4, 2005, Pages 1391-1396

  Losapio, Jennifer L ^a   Sprague, Randy S ^a   Lonigro, Andrew J ^a   Stephenson, Alan H ^a,b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b Dept of Pharmacological and Physiological Science ^*  (United States)

Author keywords

Cytochrome P 450; Isolated vessels; Lung; Myosin light chain phosphatase; U 46619; Y 27632

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; CALCIUM ION; FASUDIL; MYOSIN LIGHT CHAIN; POTASSIUM CHLORIDE; RHO KINASE; THROMBOXANE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; RABBIT; RECEPTOR OCCUPANCY; SMOOTH MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; 8,11,14-EICOSATRIENOIC ACID; AMIDES; ANIMALS; CALCIUM CHLORIDE; ENZYME ACTIVATION; ENZYME INHIBITORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; POTASSIUM CHLORIDE; PROTEIN-SERINE-THREONINE KINASES; PULMONARY ARTERY; PYRIDINES; RABBITS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 29544450461     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00473.2005     Document Type: Article

References (42)

1. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, and Takeshit A. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94: 385-393, 2004.
2. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
3. Corey EJ, Niwa H, and Falck JR. Selective epoxidation of eicosa-cis-5,8,11,14-tetraenoic (arachidonic) and eicosa-cis-8,11,14-trienoic acid. J Am Chem Soc 101: 1586-1587, 1979.
4. Eckman DM, Hopkins N, McBride C, and Keef KD. Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid. Br J Pharmacol 124: 181-189, 1998.
5. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, and McMurtry IF. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L656-L664, 2004.
6. Fang X, Kaduce TL, VanRollins M, Chatterjee P, and Spector AA. Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 277: H2098-H2108, 1999.
7. Gebremedhin D, Harder DR, Pratt PF, and Campbell WB. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 35: 274-284, 1998.
8. Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, and Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol Heart Circ Physiol 263: H519-H525, 1992.
9. + channels in porcine coronary artery smooth muscle cells. J Cardiovasc Pharmacol 32: 642-649, 1998.
10. Hecker M, Bara AT, Bauersachs J, and Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 481: 407-414, 1994.
11. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflügers Arch 417: 21-28, 1990.
12. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol 230: 215-221, 1993.
13. Hyvelin JM, O'Connor C, and McLoughlin P. Effect of changes in pH on wall tension in isolated rat pulmonary artery: role of the RhoA/Rho-kinase pathway. Am J Physiol Lung Cell Mol Physiol 287: L673-L684, 2004.
14. 2+ sensitization of prostaglandin F-2 alpha-induced contraction of rabbit aortae. J Physiol 546: 823-836, 2003.
15. Janssen LJ, Chao HL, and Netherton S. Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase. Am J Physiol Lung Cell Mol Physiol 280: L666-L674, 2001.
16. Janssen LJ and Tazzeo T. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301: 1060-1066, 2002.
17. Kamm KE and Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25: 593-620, 1985.
18. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, and Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49: 157-230, 1997.
19. Kitazawa T, Eto M, Woodsome TP, and Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
20. Martin C, Göggel R, Ressmeyer AR, and Uhlig S. Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L250-L257, 2004.
21. Mercier F, Morin C, Cloutier M, Proteau S, Rokach J, Powell WS, and Rousseau E. 5-oxo-ETE regulates tone of guinea pig airway smooth muscle via activation of Ca2+ pools and Rho-kinase pathway. Am J Physiol Lung Cell Mol Physiol 287: L631-L640, 2004.
22. Mita M, Yanagihara H, Hishinuma S, Saito M, and Walsh MP. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364: 431-440, 2002.
23. Mombouli JV and Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s)-updating the unknown. Trends Pharmacol Sci 18: 252-256, 1997.
24. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, and Oka M. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287: L665-L672, 2004.
25. Randriamboavonjy V, Busse R, and Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41: 801-806, 2003.
26. Robertson TP, Dipp M, Ward JPT, Aaronson PI, and Evans AM. Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol 131: 5-9, 2000.
27. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function (Review). Physiol Rev 82: 131-185, 2002.
28. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93: 548-556, 2003.
29. Sasaki Y, Suzuki M, and Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 93: 225-232, 2002.
30. +)ATPase. Nature 314: 620-622, 1985.
31. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
32. Stephenson AH, Sprague RS, and Lonigro AJ. 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog. Am J Physiol Heart Circ Physiol 275: H100-H109, 1998.
33. Stephenson AH, Sprague RS, Losapio JL, and Lonigro AJ. Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. Am J Physiol Heart Circ Physiol 284: H2153-H2161, 2003.
34. Sylvester JT. The tone of pulmonary smooth muscle: ROK and Rho music? Am J Physiol Lung Cell Mol Physiol 287: L624-L630, 2004.
35. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
36. Wang ZQ, Jin NJ, Ganguli S, Swartz DR, Li L, and Rhoades RA. Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol Biol 25: 628-635, 2001.
37. Yaghi A, Webb CD, Scott JA, Mehta S, Bend JR, and McCormack DG. Cytochrome P450 metabolites of arachidonic acid but not cyclooxygenase-2 metabolites contribute to the pulmonary vascular hyporeactivity in rats with acute Pseudomonas pneumonia. J Pharmacol Exp Ther 297: 479-488, 2001.
38. Zeldin DC, Plitman JD, Kobayashi J, Miller RF, Snapper JR, Falck JR, Szarek JL, Philpot RM, and Capdevila JH. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance. J Clin Invest 95: 2150-2160, 1995.
39. Zhao Y, Rhoades RA, and Packer CS. Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation. Am J Physiol Lung Cell Mol Physiol 270: L768-L774, 1996.
40. Zhu D, Birks EK, Dawson CA, Patel M, Falck JR, Presberg K, Roman RJ, and Jacobs ER. Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am J Physiol Heart Circ Physiol 279: H1526-H1533, 2000.
41. Zhu DL, Bousamra M, Zeldin DC, Falck JR, Townsley M, Harder DR, Roman RJ, and Jacobs EM. Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 278: L335-L343, 2000.
42. +-channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.